Heterologous Fibrin Biopolymer for Post-Extraction Alveolar Bone Healing in Streptozotocin-Induced Diabetic Rats
Journal of Functional Biomaterials · 03.08.2026 · 17 (8) · 380
DOI: 10.3390/jfb17080380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 03.08.2026. Verfasst von Suelen Paini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Bauru School of Dentistry (FOB), University of São Paulo (USP), Bauru 17012-901, SP, Brazil. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Type 1 diabetes mellitus (DM1) is characterized by autoimmune destruction of pancreatic β-cells, resulting in insulin deficiency and persistent hyperglycemia, which impair bone metabolism and compromise post-extraction alveolar bone healing. Heterologous fibrin biopolymer (HFB) has previously demonstrated biocompatibility, biodegradability, bioactivity, and osteoconductive properties under normoglycemic conditions. Therefore, the study investigated the association of HFB with post-extraction alveolar bone healing in streptozotocin-induced diabetic rats, using the diabetic blood clot as a biological control. Forty-eight adult male Wistar rats were induced to DM1 by a single intraperitoneal injection of streptozotocin (52 mg/kg). Animals were included after confirmation of hyperglycemia (fasting blood glucose ≥ 250 mg/dL) measured seven days after STZ administration: blood clot (BCG; n = 24) or HFB (HFBG; n = 24). Seven days after DM1 induction, the right maxillary incisor was extracted, and the sockets were filled according to group allocation. Animals were euthanized at 7, 14, and 42 days post-extraction. Fasting blood glucose levels were monitored, and pancreatic insulin immunohistochemistry was performed to characterize the diabetic condition. Alveolar bone healing was assessed by micro-CT, histological (HE), histomorphometric, and picrosirius red analyses. The diabetic phenotype was confirmed by persistent fasting hyperglycemia (260–589 mg/dL) and reduced pancreatic insulin immunostaining in β-cells. At 42 days, bone volume (BV) was 31.86% higher in the HFBG than in the BCG (p < 0.05). BCG exhibited higher trabecular number (Tb.N), while HFBG exhibited higher trabecular thickness (Tb.Th) (p < 0.05). Histologically, the HFBG shows a more mature, compact, and organized bone structure, whereas the BCG presents bone tissue with a more trabecular and immature architecture. HFBG showed the lowest percentage of thin fibers at the late stage, whereas BCG maintained similar values from 14 to 42 days (p < 0.05). These findings suggest that HFB was associated with favorable changes in selected late-stage parameters of post-extraction alveolar bone healing in an STZ-induced diabetic model.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Sciences, Bauru School of Dentistry (FOB), University of São Paulo (USP), Bauru 17012-901, SP, Brazil.
- Center for the Study of Venoms and Venomous Animals (CEVAP), Botucatu Medical School (FMB), São Paulo State University (UNESP), Botucatu 18610-307, SP, Brazil.
- Professional Graduate Program in Clinical Research, Botucatu Medical School (FMB), São Paulo State University (UNESP), Botucatu 18618-687, SP, Brazil.
- Center for Translational Science and Biopharmaceutical Development (CTS-CEVAP), São Paulo State University (UNESP), Botucatu 18610-307, SP, Brazil.
- Department of Diagnosis and Surgery, Araçatuba School of Dentistry (FOA), São Paulo State University (UNESP), Araçatuba 16015-050, SP, Brazil.
- Postgraduate Program in Comparative and Translational Veterinary Anatomy, Faculty of Veterinary Medicine and Animal Science (FMVZ), University of São Paulo (USP), São Paulo 05508-270, SP, Brazil.
ORCID-Profile: Tania Mary Cestari, Rafael Carneiro Ortiz, Rui Seabra Ferreira, Benedito Barraviera, Nathália Dantas Duarte, Rogerio Leone Buchaim, Gustavo Pompermaier Garlet
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Brazilian Federal Agency for Support and Evaluation of Graduate Education
- Center for Translational Science and Biopharmaceutical Development
- lyophilization multi-user equipment
Zitieren
APA
Paini, S., Cestari, T. M., Bighetti, A. C. C., Ortiz, R. C., Ferreira, R. S., Barraviera, B., Duarte, N. D., Buchaim, R. L., da Silva, E. L. R., Pagani, B. T., Garlet, G. P., de Assis, G. F., & Buchaim, D. V. (2026). Heterologous Fibrin Biopolymer for Post-Extraction Alveolar Bone Healing in Streptozotocin-Induced Diabetic Rats. Journal of Functional Biomaterials, 17(8), 380. https://doi.org/10.3390/jfb17080380
Vancouver
Paini S, Cestari TM, Bighetti ACC, Ortiz RC, Ferreira RS, Barraviera B, et al. Heterologous Fibrin Biopolymer for Post-Extraction Alveolar Bone Healing in Streptozotocin-Induced Diabetic Rats. Journal of Functional Biomaterials. 2026;17(8):380. doi:10.3390/jfb17080380
BibTeX
@article{Paini2026,
author = {Paini, Suelen and Cestari, Tania Mary and Bighetti, Ana Carolina Cestari and Ortiz, Rafael Carneiro and Ferreira, Rui Seabra and Barraviera, Benedito and Duarte, Nathália Dantas and Buchaim, Rogerio Leone and da Silva, Evelyn Lorene Rodrigues and Pagani, Bruna Trazzi and Garlet, Gustavo Pompermaier and de Assis, Gerson Francisco and Buchaim, Daniela Vieira},
title = {Heterologous Fibrin Biopolymer for Post-Extraction Alveolar Bone Healing in Streptozotocin-Induced Diabetic Rats},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {8},
pages = {380},
doi = {10.3390/jfb17080380}
}
EUVIMED